This suggests that RHOB expression levels determine the efficacy of EGFR signaling and led us to hypothesize that RHOB levels could account for the initial sensitivity of tumor cells to EGFR‐TKI through a mechanism that may involve EGFR‐dependent AKT signaling. The gene discussed is EGFR; the disease is neoplasm.